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AttenuationWest Nile virus (WNV) was ﬁrst detected in Texas in 2002. During 2003, several isolates exhibiting
signiﬁcant attenuation of mouse neuroinvasiveness, and in some cases a small plaque and temperature
sensitive phenotype when compared to other North American WNV isolates, were obtained from birds and
mosquitoes in South-East Texas. To determine the attenuation markers of WNV, we have sequenced the
genomes of three attenuated isolates and four temporally related virulent isolates and compared the amino
acid substitutions in a total of 101 isolates, including three previously published genomes of attenuated
strains, to identify mutations that are potentially involved in attenuation. Surprisingly, the attenuated strains
fall into three separate “groups”, suggesting that the attenuated phenotype evolved on three separate
occasions in 2003. None of the groups share the same nucleotide changes or amino acid substitutions, and
there are few mutations that can be clearly deﬁned alone as being associated with attenuation.University of Texas Medical
72 6663.
sease Control and Prevention,
e and medical microbiology,
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
AlthoughWest Nile virus (WNV), a mosquito-borne ﬂavivirus, was
ﬁrst identiﬁed in 1937 in Africa, it caused little disease in humans and
as a result was largely ignored until it was isolated in New York City
during the summer of 1999 (Lanciotti et al., 1999). Since that time,
WNV has spread rapidly across the United States, north into Canada
and south into Central and South America, infecting more than
1 million people, causing clinical disease in more than 29,000 people
in the US alone, and killing more than 1100 (http://www.cdc.gov/
Features/WestNileVirus/). In North America, WNV circulates mainly
in Culex speciesmosquitoes and birds, in particular Passeriformes, with
humans and horses usually acting as dead-end hosts (Komar, 2003).
WNV is a small icosahedral virus with an approximately 11 kb single-
stranded, positive-sense RNA genome encoding a single open reading
frame which is translated into a polyprotein co- and post-transla-
tionally processed into ten proteins; three structural (core (C),
premembrane/membrane (prM/M) and envelope (E)) and seven
non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), plus 5′
and 3′ untranslated regions (UTRs) (Rice, 1996).
Sequencing of WNV isolates from around the world have shown
the division of isolates into six distinct genotypes; Lineages 1, 2, 3 and4, with lineage 1 consisting of Clades 1a, 1b and 1c (Berthet et al.,
1997; Lanciotti et al., 2002, 1999; Savage et al., 1999; Scherret et al.,
2001). All isolates from the Americas fall into Clade 1a, along with
most isolates from Europe and the Middle East, and some isolates
from North Africa. Due to the increased interest in WNV since its
spread across the US, a large number of complete WNV genomes are
available in GenBank. Most of these are isolates from North America,
allowing in-depth analysis of the evolution of the virus since its
introduction in 1999. Surprisingly, few mutations have become ﬁxed
in WNV isolates as it has spread across the US and it has not
undergone strong positive selection (Beasley et al., 2003; Bertolotti et
al., 2007; Ebel et al., 2004; Grinev et al., 2008; Herring et al., 2007;
Snapinn et al., 2007; Tang et al., 2008). The rate of mutation has been
estimated at between 3×10−4 (Snapinn et al., 2007) and 8.5×10−4
(Bertolotti et al., 2008) substitutions per site per year, which is
comparable to mutation rates estimated previously for other
mosquito-borne ﬂaviviruses (Baillie et al., 2008; Bryant et al., 2007;
Hanada et al., 2004; Jenkins et al., 2002). Since its introduction into
North America, the dominant genotype has changed from the
introduced “NY99” genotype to the “North American” or “WN02”
genotype, characterized by a single amino acid substitution in the E
protein, E-V159A (Beasley et al., 2003; Davis et al., 2003, 2005; Ebel
et al., 2004).
WNV was ﬁrst detected in Texas in 2002, and in 2003 a small
number of isolates attenuated for mouse neuroinvasiveness were
identiﬁed in birds and mosquitoes in South-East Texas (Davis et al.,
2004). Previous studies (Davis et al., 2004, 2007) have examined the
mutations in some of these attenuated isolates compared to the NY99
strain, and introduced the amino acid substitutions found in one of
these isolates, Bird1153, into an infectious clone based on the NY99
9Rapid Communicationstrain. These studies showed that a combination of amino acid
substitutions in the NS4B and NS5 proteins, and nucleotide changes in
the 3′ UTR conferred an attenuated phenotype on the virulent NY99
strain (Davis et al., 2007). We have sequenced the complete genome
of three additional attenuated isolates and four virulent isolates, all
from birds andmosquitoes in South-East Texas during 2002 and 2003.
The isolates chosen were closely related to each other based on the E
gene sequences available in GenBank. Phylogenetic analysis shows
that the attenuated isolates fall into three different genetic groups,
and each group has different nucleotide changes and amino acid and
nucleotide substitutions that deﬁne the attenuated strains. In some
cases, there is no direct link between amino acid substitutions and
virulence, conﬁrming our previous studies with Bird1153 (Davis et al.,
2007) that attenuation may not be directly related to speciﬁc amino
acid substitutions, rather, attenuation may be caused by a combina-
tion of amino acid substitutions and non-coding nucleotide changes.
Results and discussion
Table 1 shows isolation information and accession numbers of all
the isolates discussed herein. Phylogenetic analysis of all complete
genomes of WNV isolates from the Americas is shown in Supple-
mentary Fig. S1. A simpliﬁed version of the maximum likelihood tree
showing only those isolates pertaining to this study is shown in Fig. 1.
Due to the paucity of phylogenetically informative sites in North
American isolates of WNV, there is considerable variation in some
branching of the tree, and the bootstrap values for some nodes are
low. The six attenuated isolates from the Texas Gulf Coast fall into
three distinct and well supported groups (denoted as Groups 1, 2 and
3), but the speciﬁc order of divergence within groups, especially
Group 2, is not well supported (Fig. 1). The attenuated isolates in
Groups 1 and 3 are temperature sensitive when grown in cell culture
at 39.5 °C compared to 37 °C (Tables 2 and 4), while those in Group 2
are only moderately temperature sensitive or lack temperature
sensitivity (Table 3). All attenuated isolates have small or medium
plaqueswhen comparedwith the large plaquemorphology of virulent
isolates (Davis et al., 2004).
Group 1 contains Bird1153, an attenuated strain isolated from a
mourning dove in Harris County, 2003. This strain has been studied
extensively by our group (Davis et al., 2004, 2007), mostly in
comparison to the NY99 genotype, and the attenuated phenotype
was found to be due to a combination of two amino acid substitutions
at NS4B-249 and NS5-804 plus mutations in the 3′UTR. In addition to
Bird1153, phylogenetic analysis shows that Group 1 contains another
attenuated strain, Bird1171, isolated from a great-tailed grackle in
Harris County, 2003. The closest virulent isolate is Bird114, isolated
from a blue jay in Harris County during 2002. Table 2 shows aTable 1
Viruses used in this study.
Virus name Accession number Year County Source
Bird114 GU827998 2002 Harris Blue jay
Bird1153 AY712945 2003 Harris Mourning dove
Bird1171 AY712946 2003 Harris Great-tailed gra
v4095 GU828002 2003 Harris Culex quinquefas
v4380 GU828001 2003 Harris Culex quinquefas
Bird1881 GU828003 2003 Jefferson Mourning dove
v4369 AY712948 2003 Harris Culex quinquefas
Bird1519 GU828004 2003 Montgomery Blue jay
Bird1576 GU827999 2003 Montgomery Blue jay
Bird1175 GU828000 2003 Harris Blue jay
TX2003 (82229) DQ164199 2003 Unknown Human-plasma
a Attenuation is deﬁned as an LD50 N100.
b Previously published in Davis et al. (2004).
c Both small and large plaques measured.
d A temperature sensitive phenotype is deﬁned as a reduction of titer by N2.5 log10 PFU/
e No virus was isolated from sample TX2003 so biological assays were not able to be percomparison of Bird1153, Bird1171 and Bird114, along with the
putative sequence of a most recent common ancestral virus, based
on the sequences of other closely related North American WNV
isolates. The two attenuated strains in this group share three amino
acid substitutions in the coding region (prM-V156I, NS4B-E249G and
NS5-A804V), six non-coding changes in the open reading frame and
one nucleotide change in the 3′ UTR (A to G at nucleotide 10799)
when compared with the virulent Bird114 strain. The coding changes
in the attenuated strains in this group have been analyzed in detail
previously and it was determined that a combination of mutations in
Bird1153, speciﬁcally NS4B-E249G in combination with either NS5-
A804V or an exchange involving the entire 3′UTR, attenuates the
NY99 infectious clone, which is derived from a virulent strain of the
NY99 genotype (Davis et al., 2007). The isolates in Group 1 share six
non-coding changes since divergence from other WNV isolates.
Bird1171 has additional two coding changes, both in NS5 (NS5-
R200L and NS5-A688D), when comparedwith Bird1153while there is
a single non-coding change in Bird114 since divergence from themost
recent common ancestor.
Although Group 2 itself is phylogenetically well supported, the
branching within the group is not (Fig. 1). Thus, the exact orders of
divergence of the isolates within the group are difﬁcult to determine.
This group contains one virulent isolate, v4095, from a mosquito pool
in Harris County, and four attenuated isolates, v4369, from amosquito
pool in Harris County, Bird1519, from a blue jay in Montgomery
County, v4380, also from a mosquito pool in Harris County and
Bird1881, from amourning dove in Jefferson County. All were isolated
in 2003. Amino acid substitutions and nucleotide mutations for this
group are shown in Table 3. Comparison of the amino acid sequences
of the isolates in this group with other WNV isolates reveals two
amino acid substitutions and four non-coding changes shared by all
isolates in this group, and deﬁne the divergence of this group
(Table 3). Since the most divergent isolate in this group is the
attenuated strain Bird1519 (supported by a bootstrap of 99.4%), and
four of the ﬁve strains in group 2 are attenuated, it is likely that the
most recent common ancestor of Group 2 exhibited the attenuated
phenotype. This phenotype may have occurred with the evolution of
one or both of the amino acid substitutions at prM-N5D and NS5-
H296Y, in combination with some or all of the non-coding nucleotide
changes that are shared by all isolates in this group. The asparagine at
residue prM-N5 is completely conserved in all WNV isolates
sequenced to date and virulence studies with a mutated NY99-
based infectious clone show no attenuation with this substitution
alone (C.T. Davis, S.E. Galbraith and A.D.T. Barrett, unpublished
results). This residue is on the surface of the prM protein (Li et al.,
2008), in a region that is highly variable among ﬂaviviruses. Residue
NS5-H296 is conserved in all other isolates from Clades 1a, 1b and 1c.Group Virulencea
(LD50)
Plaque size TSd (37 °C/39.5 °C)
1 Virulent (4.2)b lpb −0.2b
1 Attenuated (≥1000)b spb 2.7b
ckle 1 Attenuated (≥1000)b spb 2.7b
ciatus 2 Virulent (≤100)b lpb 0.2b
ciatus 2 Attenuated (≥100)b Mixedb,c 0.3b
2 Attenuated (≥1000)b mixedb,c 0.3b
ciatus 2 Attenuated (≥1000)b spb 1.8b
2 Attenuated (≥1000)b spb 0.3b
3 Virulent (0.3) lp 0.2
3 Attenuated (≥1000)b spb 2.5b
3 NDe NDe NDe
ml at 39.5 °C when compared with 37 °C.
formed.
Fig. 1. The section of the maximum likelihood tree showing the WNV isolates discussed. The full tree is Supplementary Fig. 1. For clarity, this tree was constructed using complete
genomes of the isolates discussed here. Virulent isolates are shown in red, attenuated isolates in blue. Percent bootstraps (of 1000 replicates) are shown at the nodes.
10 Rapid CommunicationIsolates in Lineages 2, 3 and 4 have a glutamine at this position; no
other isolates have a tyrosine. This residue is located in the RNA-
dependent RNA-polymerase (RdRp) portion of the NS5 protein, and is
located in the ﬁngers domain, on the outer surface of the protein
(Malet et al., 2007). Substitution of this residue, in combination with
NS4B-T241A (found in the attenuated strain v4369), in the NY99-
based infectious clone does not affect virulence (C.T. Davis, S.E.
Galbraith and A.D.T. Barrett, unpublished results). Since neither of
these amino acid substitutions attenuates the virus alone, the
attenuated phenotype of these isolates must be the result of a
combination of factors, most likely including changes in RNA structure
and/or interactions between the RNA and the protein. Few studies
have shown exactly how the structure of the RNA of ﬂaviviruses
interacts with the replication complex or other aspects of virus
replication and assembly, and most have focused exclusively on the
UTRs. There are no nucleotide changes in either UTRs that are present
in all attenuated isolates in this group, although one of the attenuated
isolates (v4369) has a change at nucleotide 10984 (A to T) in the
highly conserved penta-nucleotide motif in the stem loop of the 3′
UTR. Mutation of this nucleotide to any nucleotide other than A has
been previously shown to abolish RNA synthesis (Tilgner et al., 2005)
but although this isolate is attenuated, it is able to replicate in cell
culture and as such must be able to synthesize RNA. There are
additional three nucleotide changes in the genome of this isolate,
including one amino acid substitution, NS4B-T241A. As discussed
above, this amino acid substitution (in combination with NS5-H296Y)
does not attenuate the NY99-based infectious clone (S.E. Galbraith
and A.D.T. Barrett, unpublished results), but either alone or incombination with the other nucleotide changes may interact with
the penta-nucleotide motif and restore the ability to synthesize viral
RNA.
Surprisingly, the virulent phenotype of strain v4095 appears to be
a reversion from the attenuated ancestor of this group to a mouse
virulent phenotype similar to that seen in most North American WNV
isolates. This isolate contains ﬁve non-coding changes (one of which is
in the 3′UTR, at nucleotide 10449) and one coding change, NS5-Q515P
(all changes summarized in Table 3). One or more of these changes
may be compensatory mutations, resulting in the reversion to a
virulent phenotype. The glutamine at NS5-Q515 is completely
conserved in all other WNV genomes and is in the palm domain of
the RdRp at the bottom of the RNA output tunnel (Malet et al., 2007).
This residue is close to residue NS5-512, which has been shown to
interact with themethyltransferase region of NS5 (Zhang et al., 2008).
If the attenuation of Group 2 is due to impairment of the interaction
between NS5 and the RNA (affecting RNA transcription), a combina-
tion of these changes may compensate and correct for this
impairment.
Two nucleotide changes, both in the open reading frame (C to T at
nucleotide 8052 and C to T at nucleotide 10230, both in the NS5 gene)
occur in more than one isolate in Group 2. No isolates after 2003 are
closely related to these isolates (see Supplementary Fig. 1), suggesting
that this genotype has become extinct. This group is unique in that
isolates reverted to amouse virulent phenotype after initially evolving
to a mouse attenuated phenotype. Given that the exact order of
divergence of these isolates is unclear due to low bootstrap values
caused by few phylogenetically informative sites, the attenuation and
Table 2
Phenotypic properties, amino acid substitutions and nucleotide changes among Group 1 isolates. Italicized and underlined codons/nucleotides are those that differ from the putative
sequence of the most recent common ancestor (MRCA).
prM E NS1 NS2A NS3 NS4A NS4B
Strain 931
(156)
1065
(33)
1137
(57)
1851
(295)
2656
(63)
3774
(83)
5634
(341)
5652
(347)
6726
(86)
7661 (249)
Bird114 GTC/Val ATT/Ile CGT/Arg TTG/Leu TTG/Leu TTT/Phe CCG/Pro TCT/Ser GTT/Val GAA/Glu
Bird1171 ATC/Ile ATT/Ile CGC/Arg TTA/Leu TTG/Leu TTT/Phe CCA/Pro TCC/Ser GTT/Val GGA/Gly
Bird1153 ATC/Ile ATT/Ile CGC/Arg TTA/Leu TTG/Leu TTT/Phe CCA/Pro TCC/Ser GTT/Val GGA/Gly
MRCA sequence GTC/Val ATC/Ile CGC/Arg TTG/Leu CTG/Leu TTC/Phe CCG/Pro TCT/Ser GTC/Val GAA/Glu
NS5 3′UTR
Strain 8279
(200)
8301
(207)
8322
(214)
8502
(274)
9159
(493)
9743
(688)
10091
(804)
10305
(875)
10799
Bird114 CGC/Arg GTT/Val AAC/Asn TCA/Ser TTT/Phe GCT/Ala GCA/Ala GTC/Val A
Bird1171 CTC/Leu GTT/Val AAC/Asn TCG/Ser TTC/Phe GAT/Asp GTA/Val GTT/Val G
Bird1153 CGC/Arg GTT/Val AAC/Asn TCG/Ser TTC/Phe GCT/Ala GTA/Val GTT/Val G
MRCA sequence CGC/Arg GTC/Val AAT/Asn TCA/Ser TTT/Phe GCT/Ala GCA/Ala GTC/Val A
11Rapid Communicationreversion to virulence of these isolates may be multifactorial and
remains unclear without further studies examining the potential
changes on the virulence of an infectious clone.
Group 3 contains one virulent strain, Bird1576, a blue jay isolate
from Montgomery County, Texas, one attenuated strain, Bird1175,
also isolated from a blue jay, in Harris County, Texas and one strain
of unknown virulence, TX2003, a blood donor sample from Texas
(Table 4). All isolates in this group were isolated in 2003 and Harris
and Montgomery Counties are adjacent to each other in South-East
Texas. Unfortunately, the sequence of TX2003 was derived from
RNA directly from the blood sample, and no virus was isolated, so
this isolate could not be biologically characterized. Comparison of
the nucleotide and amino acid alignments of the genomes of these
strains reveals 14 non-coding mutations and four amino acid
substitutions in the polyprotein, of which four non-coding changes
are shared by all members of this group. In addition, there are three
nucleotide changes in the 3′ UTR. These mutations are summarized
in Table 4. Of these, only one amino acid substitution, C-R32S, occurs
in the attenuated isolate, Bird1175, only. The remaining coding
substitutions and the changes in the 3′ UTR are in either the virulent
isolate or the isolate with unknown virulence, while at these
nucleotide positions, the attenuated isolate is identical to at least
one of the virulent isolates. Of the non-coding changes, only two, C
to T at nucleotide 4804 and T to A at nucleotide 5994 (both in the
NS3 gene) occur in the attenuated strain only. The substitution, C-
R32S is in helix α1 in the structure of C protein, which has been
shown to be essential for the function of the protein. The arginine
residues in the core protein increase the positive charge of the
protein, promoting binding to the negatively charged RNA. The
change from an arginine to a serine will reduce the positive charge
of the protein, potentially impairing the ability of the protein to bind
correctly to the RNA (Khromykh and Westaway, 1996). If this amino
acid substitution changes the binding of the C protein to the RNA,
the two non-coding changes, C to T at nucleotide 4804 and T to A at
nucleotide 5994 may be compensatory mutations adjusting the RNA
structure to accommodate the substitution in the C protein. This
group has accumulated four non-coding changes since divergence,
also shown in Table 4.
As demonstrated above, phenotypic changes (attenuation of
mouse neuroinvasiveness, temperature sensitivity and plaque size)
of WNV strains from South-East Texas were detected on at least three
occasions in 2003, each time via a different set of mutations and likely
a different mechanism of attenuation. Groups 1 and 3 have a virulent
ancestor, with one or two attenuated strains occurring at the terminal
nodes. Attenuation in Group 3 may be due to a mutation in the C
protein, while attenuation in Group 1 has been shown to involve acombination of mutations in the NS4B and NS5 proteins, and the 3′
UTR. In contrast, Group 2 has an attenuated ancestor, with evolution
to the virulent strain representing a reversion, rather than vice versa.
The initial attenuation of this group may have been the result of two
coding changes, one in the prM protein and one in the NS5 protein, in
combination with non-coding changes. The reversion to virulence of
strain v4095 may be due to a single amino acid substitution, also in
the NS5 protein, and one nucleotide change in the 3′ UTR. Both NS5
substitutions (attenuating, then reverting to virulence) occur in the
RdRp portion of the protein, suggesting an initial impairment of the
RNA interaction, or the function of the protein, followed by a
compensating mutation.
The majority of the nucleotide changes in WNV isolates in the
Americas are the result of genetic drift, and most of the amino acid
substitutions do not become ﬁxed in the population (Beasley et al.,
2003; Bertolotti et al., 2007; Ebel et al., 2004; Grinev et al., 2008;
Herring et al., 2007; Snapinn et al., 2007; Tang et al., 2008). In this
study we show that some of these substitutions resulted in changes in
phenotype, including attenuatedmouse neuroinvasiveness of isolates.
Genetic analysis of WNV strains in North America indicate that these
isolates appear to have no selective advantage and the attenuated
phenotype seems to result in a reduced rate of detection due to the
lack of virulence, or extinction of the genotype, observed as a lack of
new isolates in that branch of the phylogenetic tree. In some cases, a
virulent phenotype can reoccur at the terminus of the branches,
apparently caused by compensating mutations. Animal studies are
difﬁcult to justify on all isolates, thus virulence assays are not
routinely performed on new WNV isolates. We believe that
modiﬁcations of the phenotype, including the prevalence of mouse
attenuation in natural isolates, are probably higher than thought due
to few studies on the virulence phenotype. However, to date, there
appears to be no selective advantage for variants other than
derivation of the North American/WN02 genotype in 2002. None-
theless, we should not discount the possibility that a variant will
appear that has a selective advantage and will lead to ampliﬁcation of
a new genotype of WNV in North America.
Methods
Sequencing of isolates
Viral RNA was isolated from infected Vero cell supernatant using
QIAGEN QIAamp viral RNA mini kit, as per the manufacturer's
instructions. The entire genome was sequenced via consensus
sequencing of PCR products or after cloning into pGEM-Teasy
plasmids (Promega) using primers designed on the published
Table 3
Phenotypic properties, amino acid substitutions and nucleotide changes among Group 2 isolates. Italicized and underlined codons/nucleotides are those that differ from the putative sequence of the most recent common ancestor (MRCA).
prM E NS1 NS2B NS3 NS4A NS4B
Strain 478
(5)
606
(47)
1521 (185) 2656
(63)
2850
(127)
3372 (301) 4593
(124)
4617
(2)
6204
(531)
6669 (67) 6790
(108)
6849
(127)
6918 (1) 7407
(165)
7614
(233)
7636 (241)
Bird1519 GAC/
Asp
GAT/
Asp
GAA/Glu TTG/
Leu
GAA/
Glu
ACC/Thr ACC/
Thr
GGT/
Gly
AGA/
Arg
GTA/Val TTG/
Leu
TCG/
Ser
AAC/Asp CGA/
Arg
GGT/
Gly
ACA/Thr
Bird1881 GAC/
Asp
GAT/
Asp
GAA/Glu CTG/
Leu
GAG/
Glu
ACT/Thr ACT/
Thr
GGC/
Gly
AGA/
Arg
GTG/Val CTG/
Leu
TCT/
Ser
AAC/Asp CGA/
Arg
GGT/
Gly
ACA/Thr
v4369 GAC/
Asp
GAT/
Asp
GAA/Glu CTG/
Leu
GAG/
Glu
ACT/Thr ACT/
Thr
GGC/
Gly
AGA/
Arg
GTA/Val TTG/
Leu
TCG/
Ser
AAT/Asp CGA/
Arg
GGT/
Gly
GCA/Ala
V4380 GAC/
Asp
GAT/
Asp
GAA/Glu CTG/
Leu
GAG/
Glu
ACT/Thr ACT/
Thr
GGC/
Gly
AGA/
Arg
GTA/Val TTG/
Leu
TCG/
Ser
AAC/Asp CGA/
Arg
GGT/
Gly
ACA/Thr
v4095 GAC/
Asp
GAC/
Asp
GAA/Glu CTG/
Leu
GAG/
Glu
ACT/Thr ACT/
Thr
GGC/
Gly
AGG/
Arg
GTA/Val TTG/
Leu
TCG/
Ser
AAC/Asp CGA/
Arg
GGG/
Gly
ACA/Thr
MRCA sequence AAC/Asn GAT/Asp GAG/Glu CTG/Leu GAA/
Glu
ACC/Thr ACT/
Thr
GGC/
Gly
AGA/
Arg
GTA/Val TTG/
Leu
TCG/
Ser
AAC/Asp CGC/
Arg
GGT/
Gly
ACA/Thr
NS5 3′UTR
Strain 8052
(124)
8328
(248)
8470
(296)
8553
(391)
9006
(442)
9224
(515)
9453
(623)
10230
(850)
10393
(905)
10449 10984
Bird1519 GTT/
Val
ACT/
Thr
TAC/
Tyr
AGT/
Ser
GAA/
Glu
CAA/
Gln
GTA/
Val
ATT/
Ile
CTG/
Leu
T A
Bird1881 GTC/
Val
ACT/
Thr
TAC/
Tyr
AGT/
Ser
GAG/
Glu
CAA/
Gln
GTA/
Val
ATC/
Ile
CTG/
Leu
T A
v4369 GTT/
Val
ACT/
Thr
TAC/
Tyr
AGT/
Ser
GAG/
Glu
CAA/
Gln
GTA/
Val
ATC/
Ile
TTG/
Leu
T T
V4380 GTC/
Val
ACT/
Thr
TAC/
Tyr
AGT/
Ser
GAG/
Glu
CAA/
Gln
GTA/
Val
ATT/
Ile
CTG/
Leu
T A
v4095 GTC/
Val
ACT/
Thr
TAC/
Tyr
AGC/
Ser
GAG/
Glu
CCA/
Pro
GTA/
Val
ATC/
Ile
CTG/
Leu
C A
MRCA sequence GTC/
Val
ACC/
Thr
CAC/
His
AGT/
Ser
GAG/
Glu
CAA/
Gln
GTG/
Val
ATC/
Ile
CTG/
Leu
T A
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Table 4
Phenotypic properties, amino acid substitutions and nucleotide changes among Group 3 isolates. Italicized and underlined codons/nucleotides are those that differ from the putative
sequence of the most recent common ancestor (MRCA).
C prM NS1 NS2B NS3 NS4A
Strain 192
(32)
946
(161)
2495
(9)
3075
(202)
4449
(77)
4804
(65)
4896
(95)
4968
(119)
5289
(226)
5994
(461)
6433
(608)
6669
(67)
6747 (93)
Bird1576 AGG/
Arg
CTG/
Leu
AAC/
Asn
ATC/Ile GTG/
Val
CTG/
Leu
GTG/
Val
CCT/
Pro
AGA/
Arg
CGT/
Arg
TTA/
Leu
GTT/
Val
TTC/Phe
TX2003 AGG/
Arg
CTG/
Leu
AGC/
Ser
ATC/Ile GTT/
Val
CTG/
Leu
GTA/
Val
CCC/
Pro
AGG/
Arg
CGT/
Arg
CTA/
Leu
GTA/
Val
TTT/Phe
Bird1175 AGT/
Ser
CTG/
Leu
AGC/
Ser
ATC/Ile GTG/
Val
TTG/
Leu
GTA/
Val
CCC/
Pro
AGG/
Arg
CGA/
Arg
CTA/
Leu
GTA/
Val
TTC/Phe
MRCA sequence AGG/
Arg
TTG/
Leu
AGC/
Ser
ATT/Ile GTG/
Val
CTG/
Leu
GTG/
Val
CCT/
Pro
AGG/
Arg
CGT/
Arg
CTA/
Leu
GTA/
Val
TTC/Phe
NS4B NS5 3′UTR
Strain 7274
(120)
8442
(254)
8616
(312)
8724
(348)
8730
(350)
8934
(418)
9955
(759)
10119
(813)
10131
(817)
10408 10748 11015
Bird1576 TTC/
Phe
TAC/
Tyr
GAT/
Asp
ACT/
Thr
CCT/
Pro
CAA/
Gln
CTG/
Leu
GAC/
Asp
GTT/
Val
C G T
TX2003 TGC/
Cys
TAT/
Tyr
GAA/
Glu
ACC/
Thr
CCT/
Pro
CAG/
Gln
TTG/
Leu
GAT/
Asp
GTT/
Val
T A G
Bird1175 TGC/
Cys
TAT/
Tyr
GAT/
Asp
ACC/
Thr
CCT/
Pro
CAG/
Gln
CTG/
Leu
GAC/
Asp
GTT/
Val
T A T
MRCA sequence TGC/
Cys
TAC/
Tyr
GAT/
Asp
ACT/
Thr
CCC/
Pro
CAG/
Gln
CTG/
Leu
GAC/
Asp
GTC/
Val
C A G
13Rapid Communicationsequence of NY99-ﬂamingo382-99 (accession number AF196835).
RT-PCRs were performed with the Titan One-tube RT-PCR system
(Roche) as per themanufacturer's instructions (primer sequences and
PCR conditions available from authors on request). Sequencing was
performed by the Protein Chemistry and Molecular Genomics Core
Laboratories at the University of Texas Medical Branch at Galveston.
The resulting sequences were assembled into complete genome
sequences using ContigExpress in VectorNTI (Invitrogen).
Phylogenetic analysis and amino acid comparisons
Complete genomes were aligned with other complete WNV
genomes from GenBank using AlignX in the VectorNTI package
(Invitrogen). Alignments were converted to amino acids and were
visually compared using BioEdit (Hall, 1999). Bootstrappedmaximum
likelihood trees were constructed using PhyML (Guindon and Gascuel,
2003).
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